AC
ASB Consultores’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Sell |
2,518
-300
| -11% | -$55.7K | 0.31% | 59 |
|
|
2025
Q1 | $590K | Sell |
2,818
-1,959
| -41% | -$410K | 0.38% | 37 |
|
|
2024
Q4 | $849K | Buy |
4,777
+544
| +13% | +$96.7K | 0.35% | 46 |
|
|
2024
Q3 | $836K | Hold |
4,233
| – | – | 0.33% | 49 |
|
|
2024
Q2 | $726K | Sell |
4,233
-1,032
| -20% | -$177K | 0.26% | 45 |
|
|
2024
Q1 | $959K | Buy |
5,265
+3,778
| +254% | +$688K | 0.25% | 58 |
|
|
2023
Q4 | $230K | Sell |
1,487
-1,232
| -45% | -$191K | 0.08% | 94 |
|
|
2023
Q3 | $405K | Sell |
2,719
-255
| -9% | -$38K | 0.16% | 64 |
|
|
2023
Q2 | $401K | Sell |
2,974
-289
| -9% | -$38.9K | 0.19% | 103 |
|
|
2023
Q1 | $520K | Sell |
3,263
-340
| -9% | -$54.2K | 0.21% | 66 |
|
|
2022
Q4 | $582K | Sell |
3,603
-441
| -11% | -$71.3K | 0.24% | 53 |
|
|
2022
Q3 | $543K | Buy |
4,044
+172
| +4% | +$23.1K | 0.26% | 50 |
|
|
2022
Q2 | $593K | Buy |
3,872
+486
| +14% | +$74.4K | 0.26% | 40 |
|
|
2022
Q1 | $549K | Buy |
3,386
+1,365
| +68% | +$221K | 0.23% | 71 |
|
|
2021
Q4 | $274K | Buy |
+2,021
| New | +$274K | 0.14% | 167 |
|